Insilico Medicine, Takeda partner on AI-driven drug discovery
The deal could include further milestone payments, potentially bringing the total value to approximately $600m.
Drug Development
Inocras, AimedBio team up for cancer treatments
US FDA rejects approval of Unicycive’s kidney disease therapy
Beyond the GLP-1RA weight loss ceiling
Eli Lilly and Innovent agree Verzenios commercialisation deal in China
Anixa Biosciences secures Korean patent for breast cancer vaccine
Zymeworks agrees to buy Theravance Biopharma for $929m
FDA issues complete response letter to Sobi’s NASP for gout
